Page last updated: 2024-11-11

pirsidomine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

pirsidomine: a sydnonimine with direct vasodilating and nitric oxide-donating properties; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9571076
CHEMBL ID3989470
SCHEMBL ID122721
MeSH IDM0198244

Synonyms (19)

Synonym
D05517
pirsidomine (usan/inn)
132722-74-8
pirsidomine
pirsidominum [inn-latin]
pirsidomina [inn-spanish]
pirsidomine [usan:inn]
pirsidomina
unii-69n2a85v5r
pirsidominum
n-p-anisoyl-3-(cis-2,6-dimethylpiperidino)sydnone imine
69n2a85v5r ,
sydnone imine, 3-(2,6-dimethyl-1-piperidinyl)-n-(4-methoxybenzoyl)-, cis-
cas-936
SCHEMBL122721
DTXSID80157728
(1z)-n-[3-[(2s,6r)-2,6-dimethylpiperidin-1-yl]oxadiazol-3-ium-5-yl]-4-methoxybenzenecarboximidate
CHEMBL3989470
(1z)-n-[3-[(2r,6s)-2,6-dimethylpiperidin-1-yl]oxadiazol-3-ium-5-yl]-4-methoxybenzenecarboximidate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (12)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's12 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (16.67%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (83.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]